• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	ZyVersa Therapeutics, Inc. (ZVSA)
	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014	Q4-CY2013
Balance Sheet Date		2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31
Fiscal Period		Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024	Q1-FY2024	Q4-FY2023
Close Price of Common Stock		0.30$	0.68$	0.61$	1.13$	2.41$	3.56$	0.75$	0.90$	0.13$	0.25$	1.93$	1.40$
Market Cap of Common Stock		1,414,375$	3,236,403$	1,574,301$	2,648,936$	2,480,362$	2,972,230$	5,696,907$
QoQ%		(56.30%)	105.58%	(40.57%)	6.80%	(16.55%)	(47.83%)
YoY%		(42.98%)	8.89%	(72.37%)
Common Shares Outstanding	8,095,921	8,095,921	4,873,456	2,568,191	2,508,191	1,074,196	834,896	834,896	402,205	124,336	67,626	26,319	257,604
QoQ%	.00%	66.12%	89.76%	2.39%	133.50%	28.66%	.00%	107.58%	223.48%	83.86%	156.95%	(89.78%)
YoY%	222.78%	653.67%	483.72%	207.61%	523.61%	763.95%	1,134.58%	3,072.22%	56.13%
Price to Sales		-	-	-	-	-	-	-
Price to Earnings		-	-	-	-	-	-	-
Price to Book		-	.53x	.19x	.31x	.35x	.34x	.51x
Total Revenue		(131,350$)	(130,036$)	(119,559$)	(138,062$)	(131,635$)	(58$)	(101$)	(98$)	(210$)	(314$)	1,078$
QoQ%		(1.01%)	(8.76%)	13.40%	(4.88%)	(226,856.90%)	42.57%	(3.06%)	53.33%	33.12%	(129.13%)
YoY%		.22%	(224,100.00%)	(118,275.25%)	(140,779.59%)	(62,583.33%)	81.53%	(109.37%)
TTM		(519,007$)	(519,292$)	(389,314$)	(269,856$)	(131,892$)	(467$)	(723$)	456$
TTM_QoQ%		.06%	(33.39%)	(44.27%)	(104.60%)	(28,142.40%)	35.41%	(258.55%)
TTM_YoY%		(293.51%)	(111,097.43%)	(53,747.03%)	(59,278.95%)
Gross Margin		100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
QoQ		.00%	.00%	.00%	.00%	.00%	.00%	.00%	.00%	.00%	.00%
YoY		.00%	.00%	.00%	.00%	.00%	.00%	.00%
Operating Income		(20,752,130$)	(2,044,132$)	(2,144,571$)	(1,286,599$)	(2,269,621$)	(2,753,978$)	(2,826,636$)	(13,934,470$)	(2,902,678$)	(86,325,005$)	(4,592,079$)
QoQ%		(915.21%)	4.68%	(66.69%)	43.31%	17.59%	2.57%	79.72%	(380.06%)	96.64%	(1,779.87%)
YoY%		(814.34%)	25.78%	24.13%	90.77%	21.81%	96.81%	38.45%
TTM		(26,227,432$)	(7,744,923$)	(8,454,769$)	(9,136,834$)	(21,784,705$)	(22,417,762$)	(105,988,789$)	(107,754,232$)
TTM_QoQ%		(238.64%)	8.40%	7.47%	58.06%	2.82%	78.85%	1.64%
TTM_YoY%		(20.39%)	65.45%	92.02%	91.52%
Operating Margin		15,799.11%	1,571.97%	1,793.73%	931.90%	1,724.18%	4,748,237.93%	2,798,649.51%	14,218,846.94%	1,382,227.62%	27,492,039.81%	(425,981.35%)
QoQ		14,227.14%	(221.76%)	861.84%	(792.28%)	(4,746,513.75%)	1,949,588.43%	(11,420,197.43%)	12,836,619.32%	(26,109,812.19%)	27,918,021.16%
YoY		14,074.93%	(4,746,665.96%)	(2,796,855.77%)	(14,217,915.04%)	(1,380,503.44%)	(22,743,801.88%)	3,224,630.86%
Net Income		(19,805,559$)	(2,211,317$)	(2,256,930$)	(1,421,699$)	(2,401,256$)	(2,763,743$)	(2,826,737$)	(13,338,500$)	(2,902,403$)	(78,513,093$)	(3,543,950$)
QoQ%		(795.65%)	2.02%	(58.75%)	40.79%	13.12%	2.23%	78.81%	(359.57%)	96.30%	(2,115.41%)
YoY%		(724.80%)	19.99%	20.16%	89.34%	17.27%	96.48%	20.24%
TTM		(25,695,505$)	(8,291,202$)	(8,843,628$)	(9,413,435$)	(21,330,236$)	(21,831,383$)	(97,580,733$)	(98,297,946$)
TTM_QoQ%		(209.91%)	6.25%	6.05%	55.87%	2.30%	77.63%	.73%
TTM_YoY%		(20.47%)	62.02%	90.94%	90.42%
Profit Margin		15,078.46%	1,700.54%	1,887.71%	1,029.75%	1,824.18%	4,765,074.14%	2,798,749.51%	13,610,714.29%	1,382,096.67%	25,004,169.75%	(328,752.32%)
QoQ		13,377.92%	(187.17%)	857.96%	(794.42%)	(4,763,249.96%)	1,966,324.63%	(10,811,964.78%)	12,228,617.62%	(23,622,073.08%)	25,332,922.06%
YoY		13,254.28%	(4,763,373.60%)	(2,796,861.79%)	(13,609,684.53%)	(1,380,272.49%)	(20,239,095.61%)	3,127,501.82%
Equity to Common Shareholders		(11,725,567$)	6,099,774$	8,130,350$	8,516,447$	7,027,300$	8,620,055$	11,223,134$	11,074,598$	19,703,659$	20,061,642$	97,098,365$	99,662,997$
QoQ		(17,825,341$)	(2,030,576$)	(386,097$)	1,489,147$	(1,592,755$)	(2,603,079$)	148,536$	(8,629,061$)	(357,983$)	(77,036,723$)	(2,564,632$)
QoQ%		(292.23%)	(24.98%)	(4.53%)	21.19%	(18.48%)	(23.19%)	1.34%	(43.79%)	(1.78%)	(79.34%)	(2.57%)
YoY		(18,752,867$)	(2,520,281$)	(3,092,784$)	(2,558,151$)	(12,676,359$)	(11,441,587$)	(85,875,231$)	(88,588,399$)
YoY%		(266.86%)	(29.24%)	(27.56%)	(23.10%)	(64.34%)	(57.03%)	(88.44%)	(88.89%)
Dividends Paid
Additional Paid-In Capital QoQ		1,979,896$	180,511$	1,870,827$	2,910,702$	808,477$	160,664$	2,975,230$
Treasury Stock		7,168$	7,168$	7,168$	7,168$	7,168$	7,168$	7,168$	7,168$
QoQ		0$	0$	0$	0$	0$	0$	0$
Goodwill											11,895,033$		11,895,033$
QoQ%
YoY%
Other Intangible Assets
QoQ
Amortization of Intangible Assets
Total Assets		1,040,260$	19,641,111$	20,985,541$	20,599,414$	19,423,924$	19,469,504$	21,650,764$	22,114,284$				118,506,271$
QoQ		(18,600,851$)	(1,344,430$)	386,127$	1,175,490$	(45,580$)	(2,181,260$)	(463,520$)
YoY		(18,383,664$)	171,607$	(665,223$)	(1,514,870$)				(96,391,987$)
Total Liabilities		12,765,827$	13,541,337$	12,855,191$	12,082,967$	12,396,624$	10,849,449$	10,427,630$	11,039,686$				18,511,943$
QoQ		(775,510$)	686,146$	772,224$	(313,657$)	1,547,175$	421,819$	(612,056$)
YoY		369,203$	2,691,888$	2,427,561$	1,043,281$				(7,472,257$)
Current Ratio		.08x	.04x	.18x	.15x	.03x	.06x	.30x	.33x				.78x
Total Current Assets		995,533$	549,069$	2,110,310$	1,715,797$	390,415$	641,392$	2,900,052$	3,353,133$				6,362,546$
QoQ		446,464$	(1,561,241$)	394,513$	1,325,382$	(250,977$)	(2,258,660$)	(453,081$)
Total Current Liabilities		12,765,827$	12,689,678$	12,003,532$	11,231,308$	11,542,003$	9,994,828$	9,582,716$	10,194,772$				8,187,960$
QoQ		76,149$	686,146$	772,224$	(310,695$)	1,547,175$	412,112$	(612,056$)
Debt to Asset Ratio		12.27x	.69x	.61x	.59x	.64x	.56x	.48x	.50x				.16x
Long Term Debt
QoQ
YoY
Capital Lease Obligations
Cash and Cash Equivalents
QoQ
YoY
Interest Expenses		131,350$	130,036$	119,559$	138,062$	131,635$	58$	101$	98$	210$	314$	0$
Interest Income

Copy Table ✓